Brickell Biotech Inc. (United States) is listed on the Nasdaq and has a market capitalization of $109.34 Millions, with shareholders equity totaling $15.64 Millions.
The company employs approximately 13 people and operates in the Health Care sector, within the Biotechnology industry.
Over the past 12 months, Brickell Biotech Inc. reported $4.51 Millions in revenue, generating net income of $-29.88 Millions.
Key financial metrics include a P/E ratio of -3.66, a price-to-book (P/B) ratio of 6.99, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker BBI.